Article
Identification of Novel Prognostic Biomarkers to Predict Pembrolizumab Response in Gastric Cancer by Bioinformatics Analysis
2021-08-10
Abstract excerpt
<title>Abstract</title> <p>Immune checkpoint inhibitors (ICIs), especially pembrolizumab, have improved outcomes in patients with advanced or metastatic gastric cancer (GC). However, there are no reliable markers for the evaluation of its efficacy. GC samples from the UCSC Xena Browser and Gene Expression Omnibus (GEO) databases were performed by bioinformatics analysis. The single sample gene set enrichment (ssG...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 246bf05d-97f7-5dde-81a1-23ed26828d13
- DOI
- 10.21203/rs.3.rs-784591/v1
